Case 21-2007: A 58-year-old woman with headaches, weakness, and strokelike episodes

New England Journal of Medicine

Volumn 357, Issue 2, 2007, Pages 164-

  Greer, David M ^a,b   Cagliero, Enrico ^a,b   Krakauer, Eric L ^a,b   Gonzalez, R Gilberto ^a,b   Hedley Whyte, E Tessa ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA1A INTERFERON; FLUORODEOXYGLUCOSE F 18; HEPARIN; INSULIN GLARGINE; INSULIN I 131; INSULIN LISPRO; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN DISEASE; CASE REPORT; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HOSPITAL ADMISSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEOPLASM; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE; TREATMENT RESPONSE; VISUAL IMPAIRMENT; BRAIN; BRAIN INFARCTION; BRAIN TUMOR; CLINICAL OBSERVATION; CLINICAL STUDY; DIABETIC ANGIOPATHY; DIAGNOSIS; FATALITY; MIDDLE AGED; MIGRAINE; PATHOLOGY; SKELETAL MUSCLE; SKIN; VASCULITIS;

BRAIN; BRAIN NEOPLASMS; CEREBRAL INFARCTION; DEMYELINATING DISEASES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FATIGUE; FEMALE; HEADACHE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MIGRAINE DISORDERS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; SKIN; VASCULITIS;

EID: 34447325610     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc079015     Document Type: Article

References (37)

1. Bousser MG, Tournier-Lasserve E. Summary of the proceedings of the First International Workshop on CADASIL: Paris, May 19-21, 1993. Stroke 1994;25:704-7.
2. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223-43.
3. Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med 2000;343:938-52.
4. Feinstein A, Roy P, Lobaugh N, Feinstein K, O'Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004;62:586-90.
5. Watkins SM, Espir ML. Migraine and multiple sclerosis. J Neurol Neurosurg Psychiatry 1969;32:35-7.
6. Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlations of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-93.
7. Cepok S, Jacobsen M, Schock S, et al. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 2001;124:2169-76.
8. Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE. Neurologic abnormalities of Lyme disease. Medicine (Baltimore) 1979;58:281-94.
9. Navia BA, Jordan BD, Price RW. The AIDS dementia complex. I. Clinical features. Ann Neurol 1986;19:517-24.
10. Hirano M, Ricci E, Koenigsberger MR, et al. MELAS: an original case and clinical criteria for diagnosis. Neuromuscul Disord 1992;2:125-35.
11. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994;330:962-8.
12. McDonnell MT, Schaefer AM, Blakely EL, et al. Noninvasive diagnosis of the 3243A > G mitochondrial DNA mutation using urinary epithelial cells. Eur J Hum Genet 2004;12:778-81.
13. Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 2004;61:1366-8.
14. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-34.
15. Susac JO, Murtagh FR, Egan RA, et al. MRI findings in Susac's syndrome. Neurology 2003;61:1783-7.
16. Calabrese LH, Furlan AJ, Gragg LA, Ropos TJ. Primary angiitis of the central nervous system: diagnostic criteria and clinical approach. Cleve Clin J Med 1992;59:293-306.
17. Camilleri M. Diabetic gastroparesis. N Engl J Med 2007;356:820-9.
18. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993;328:1676-85.
19. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes: the Copenhagen Stroke Study. Stroke 1994;25:1977-84.
20. Folsom AR, Rasmussen ML, Chambless LE, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care 1999;22:1077-83.
21. Jamrozik K, Broadhurst RJ, Forbes S, Hankey GJ, Anderson CS. Predictors of death and vascular events in the elderly: the Perth Community Stroke Study. Stroke 2000;31:863-8.
22. Tuomilehto J, Borch-Johnsen K, Molarius A, et al. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 1998;41:784-90.
23. Laing SP, Swerdlow AJ, Carpenter LM, et al. Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke 2003;34:418-21.
24. Alex M, Baron EK, Goldenberg S, Blumenthal HT. An autopsy study of cerebrovascular accident in diabetes mellitus. Circulation 1962;25:663-73.
25. Aronson SM. Intracranial vascular lesions in patients with diabetes mellitus. J Neuropathol Exp Neurol 1973;32:183-96.
26. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
27. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61.
28. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992-1000. [Erratum, Mayo Clin Proc 2005;80:1101.]
29. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53. [Erratum, Lancet 1999;354:602.]
30. The Diabetes Control and Complication Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53.
31. Gæde P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93.
32. Raskin P, Pietri AO, Unger R, Shannon WA Jr. The effect of diabetic control on the width of skeletal-muscle capillary basement membrane in patients with type 1 diabetes mellitus. N Engl J Med 1983;309:1546-50.
33. Powell HC, Rosoff J, Myers RR. Microangiopathy in human diabetic neuropathy. Acta Neuropathol (Berl) 1985;68:295-305.
34. Malik RA, Tesfaye S, Newrick PG, et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005;48:578-85.
35. Tulsky JA, Ciampa R, Rosen EJ. Responding to legal requests for physician-assisted suicide. Ann Intern Med 2000;132:494-9.
36. Beauchamp TL, Childress JF. Principles of biomedical ethics. 5th ed. New York: Oxford University Press, 2001.
37. Miller FG, Fins JJ, Snyder L. Assisted suicide compared with refusal of treatment: a valid distinction? Ann Intern Med 2000;132:470-5.